COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,970 Articles (22,604 medRxiv, 8,366 bioRxiv)

Most recent first Previous |  Page 2311: Articles 23101-23110  | Next

On COVID-19-safety ranking of seats in intercontinental commercial aircrafts: A preliminary multiphysics computational perspective
Desai, P. S., Sawant, N., Keene, A.
10.1101/2020.08.17.20176909 — Posted: 2020-08-21
Pediatric surgical services in Bangladesh during the COVID 19 pandemic: How they are affected and how to overcome the backlog, keeping healthcare professionals safe.
Hannan, M. J., Parveen, M. K., Hasan, M. S.
10.1101/2020.08.16.20169979 — Posted: 2020-08-21
Real-time spatial health surveillance: mapping the UK COVID-19 epidemic
Fry, R., Hollinghurst, J., Stagg, H. R., Thompson, D. A., Fronterre, C., Orton, C., Lyons, R. A., Ford, D. V., Sheikh, A., Diggle, P. J.
10.1101/2020.08.17.20175117 — Posted: 2020-08-21
Comparing the Fit of N95, KN95, Surgical, and Cloth Face Masks and Assessing the Accuracy of Fit Checking
O'Kelly, E., Arora, A., Pirog, S., Ward, J., Clarkson, P. J.
10.1101/2020.08.17.20176735 — Posted: 2020-08-21
Summer COVID-19 third wave: faster high altitude spread suggests high UV adaptation
Seligmann, H., Vuillerme, N., Demongeot, J.
10.1101/2020.08.17.20176628 — Posted: 2020-08-21
The Mental Health of Healthcare Staff during the COVID-19 Pandemic: It Depends on How Much They Work and Their Age
Xu, X., Zhang, S. X., Afshar Jahanshahi, A., Li, J., Bagheri, A., Nawaser, K.
10.1101/2020.08.18.20173500 — Posted: 2020-08-21
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy
Mastellos, D. C., Pires da Silva, B. G. P., Fonseca, B. A. L., Fonseca, N. P., Martins, M. A., Mastaglio, S., Ruggeri, A., Sironi, M., Radermacher, P., Skendros, P., Ritis, K., Manfra, I., Iacobelli, S., Huber-Lang, M., Nilsson, B., Yancopoulou, D., Connolly, E. S., Garlanda, C., Ciceri, F., Risitano, A. M., Calado, R. T., Lambris, J. D.
10.1101/2020.08.17.20174474 — Posted: 2020-08-21
What if we perceive SARS-CoV-2 genomes as documents? Topic modelling using Latent Dirichlet Allocation to identify mutation signatures and classify SARS-CoV-2 genomes
Nagpal, S., Srivastava, D., Mande, S. S.
10.1101/2020.08.20.258772 — Posted: 2020-08-20
Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection
Freuling, C. M., Breithaupt, A., Mueller, T., Sehl, J., Balkema-Buschmann, A., Rissmann, M., Klein, A., Wylezich, C., Hoeper, D., Wernike, K., Aebischer, A., Hoffmann, D., Friedrichs, V., Dorhoi, A., Groschup, M., Beer, M., Mettenleiter, T. C.
10.1101/2020.08.19.256800 — Posted: 2020-08-20 Discussion: Offsite
A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD
Han, X., Wang, Y., Li, S., Tang, N., Hu, C., Li, T., Xie, Y., Shen, M., Wang, J., Gu, C., Hu, J., Gong, F., Wu, R., Gao, F., Huang, J., Mu, S., Luo, F., Long, Y., Song, S., Long, S., Hao, Y., Chen, Q., Li, L., Wu, Y., Xu, W., Cai, X., Gao, Q., Zhang, G., He, C., Wang, K., Deng, K., Du, L., Nai, Y., Wang, W., Huang, A., Jin, A.
10.1101/2020.08.19.253369 — Posted: 2020-08-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).